AKT1 and cancer: In addition, IP5 was shown to antagonize the PI3K pathway through inhibition of Akt, thereby inducing apoptosis across various cancer models, and additionally enhancing the proapoptotic effect of cisplatin and etoposide [373], pointing to IP5 as a specific antiangiogenic and antitumor factor [372].